About Megazyme
Megazyme is a Healthcare company based in Bray (Ireland) founded in 1988 by Barry McCleary, and was acquired by Neogen in January 2021. It operates as an analytical test kits and reagents are supplied for food analysis. Its chief executive is Barry McCleary. Its website megazyme.com draws about 49 thousand monthly visits. Megazyme offers products and services including Assay Kits, Enzymes, and Analytical Standards. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its legal entity is Megazyme Ltd. Its competitors include Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec and 5 more; 8 of its 10 listed competitors have raised funding.
Company details
Megazyme was established in 1988 in Bray, Ireland, within the analytical testing sector. A range of products is provided, encompassing analytical enzymes and assay kits focused on dietary fibre and wine analysis. Reagents, substrates including oligosaccharides, and enzyme tablet tests are supplied to support laboratory applications in food and beverage industries. Operations emphasize precise measurement tools for quality control and research purposes.
Products & Services of Megazyme
Megazyme offers a comprehensive portfolio of products and services, including Assay Kits, Enzymes, and Analytical Standards.
Kits for enzymatic assays and activity measurement in research.
Enzymes for carbohydrate analysis and industrial applications.
Standards for accurate testing in food and life sciences.
Apps and channels of Megazyme
its YouTube channel MegazymeVideos has 1.7K subscribers and 30 videos.
Videos from Megazyme
The most watched videos on Megazyme's YouTube channel, MegazymeVideos (1.7K subscribers). Click a video to play it here.
More on MegazymeVideos.
Investors in Megazyme
Megazyme has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Neogen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing | 1982 | neogen.com | Lansing, United States |
Investor details for Megazyme
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Megazyme
1 people are tracked at Megazyme (1 in leadership).
| Name | Role | Group |
|---|---|---|
Barry McCleary | Founder & CEO | Leadership |
Complete people profiles for Megazyme
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Megazyme
2 dated milestones of Megazyme across 33 years, from founding to its latest funding, stage changes and deals.
- Founded Megazyme is founded.
- Exit Acquired by Neogen.
Competitors of Megazyme
Megazyme has 10 listed competitors in our database, 8 of them funded. They include Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| miltenyibiotec.com | 1989 | Bergisch Gladbach, Germany | – | 585 | Develops tools and products for research and clinical application | |
| devyser.com | 2004 | Stockholm, Sweden | $15.48M | – | Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders | |
| exonhit.com | 1997 | Paris, France | $65.46M | – | Fully integrated in vitro diagnostics company specializing in transplantation, infectious diseases and cancer diagnosis | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits |
Detailed competitors of Megazyme
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Megazyme
The website of Megazyme (megazyme.com) receives about 48.6K visits a month.
- Monthly visits48.6K
▼ 13.4% vs previous month
Websites whose visitors overlap most with Megazyme. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bioassaysys.com | 100% | 12.4K | #2,032,630 | View details | |
| bellbrooklabs.com | 92% | 10K | #2,027,954 | View details | |
| biovision.com | 87% | – | – | View details | |
| mapsenzymes.com | 86% | – | – | View details | |
| abnova.com | 84% | 30.7K | #957,320 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 31 similar websites and full traffic analytics for Megazyme
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 31 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Megazyme (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Megazyme
Complete news archive for Megazyme
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Megazyme
Megazyme was founded in 1988.
Megazyme is headquartered in Bray, Ireland. It is registered at Bray, Wicklow, Ireland.
Barry McCleary is the current CEO of Megazyme. They have also founded this company.
Megazyme was established in 1988 in Bray, Ireland, within the analytical testing sector. A range of products is provided, encompassing analytical enzymes and assay kits focused on dietary fibre and wine analysis. Reagents, substrates including oligosaccharides, and enzyme tablet tests are supplied to support laboratory applications in food and beverage industries. Operations emphasize precise measurement tools for quality control and research purposes.
Megazyme's top competitors include Abcam, Sino Biological and Meridian Bioscience.
Megazyme offers Assay Kits, Enzymes, and Analytical Standards.
Megazyme has 1 investor. Key investors include Neogen.
Megazyme operates through Megazyme Ltd..
Yes. Megazyme was acquired by Neogen in January 2021.